Management of perioperative hypertensive urgencies with parenteral medications

Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine
Kartikya Ahuja, Mitchell H Charap

Abstract

Hypertension is the major risk factor for cardiovascular (CV) disease such as myocardial infarction (MI) and stroke. This risk is well known to extend into the perioperative period. Although most perioperative hypertension can be managed with the patient's outpatient regimen, there are situations in which oral medications cannot be administered and parenteral medications become necessary. They include postoperative nil per os status, severe pancreatitis, and mechanical ventilation. This article reviews the management of perioperative hypertensive urgency with parenteral medications. A PubMed search was conducted by cross-referencing the terms "perioperative hypertension," "hypertensive urgency," "hypertensive emergency," "parenteral anti-hypertensive," and "medication." The search was limited to English-language articles published between 1970 and 2008. Subsequent PubMed searches were performed to clarify data from the initial search. As patients with hypertensive urgency are not at great risk for target-organ damage (TOD), continuous infusions that require intensive care unit (ICU) monitoring and intraarterial catheters seem to be unnecessary and a possible misuse of resources. When oral therapy cannot be administered, patient...Continue Reading

References

Jan 1, 1975·British Journal of Anaesthesia·T J Gal, L H Cooperman
Oct 20, 1977·The New England Journal of Medicine·L GoldmanE E Slater
Mar 1, 1990·Journal of Clinical Pharmacology·G Chun, W H Frishman
Aug 1, 1989·American Journal of Surgery·P F PasternackA M Imparato
Oct 1, 1989·Archives of Internal Medicine·K R ZellerC Matthews
Jun 1, 1989·American Journal of Hypertension·S Strandgaard, O B Paulson
Dec 14, 1987·The American Journal of Cardiology·G P ReamsJ H Bauer
Aug 1, 1988·Critical Care Medicine·J P OrlowskiJ R Little
Oct 1, 1987·Journal of Clinical Pharmacology·C E HalstensonG R Matzke
Mar 1, 1986·British Journal of Anaesthesia·J MagnussonD Thomson
Jun 1, 1987·Circulation·J H Bauer, G P Reams
Sep 1, 1987·Anesthesiology·J B LeslieW D Watkins
Oct 1, 1987·Archives of Surgery·J L SkydellW S Moore
Nov 1, 1986·Archives of Internal Medicine·A S DetskyJ R Hilliard
Jan 11, 1985·JAMA : the Journal of the American Medical Association·M D SchallerH R Brunner
Oct 17, 1983·The American Journal of Medicine·D J WilsonM P Poland
May 31, 1984·The American Journal of Medicine·O B PaulsonS Vorstrup
Aug 31, 1984·The American Journal of Medicine·W H FrishmanN Beer
Aug 1, 1983·Clinical Pharmacology and Therapeutics·T M LuddenM S Lin
Jan 1, 1980·International Anesthesiology Clinics·C Prys-Roberts, R Meloche
Nov 1, 1982·British Journal of Anaesthesia·D R MorelP M Suter
Aug 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P ArmarioH Pardell
Mar 1, 1993·The Medical Clinics of North America·S D Wolfsthal
Jan 1, 1996·British Journal of Obstetrics and Gynaecology·P López-JaramilloE Nava
Jan 3, 2001·American Heart Journal·J B ShammashS E Kimmel
Mar 27, 2003·Annals of Emergency Medicine·Philip H Shayne, Stephen R Pitts
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
May 29, 2003·Journal of Clinical Anesthesia·Natan WekslerGabriel M Gurman
Oct 25, 2003·BMJ : British Medical Journal·Laura A MageePeter von Dadelszen
Jul 28, 2004·Anesthesiology·Arthur W WallaceDavid Kardatzke
Nov 2, 2004·The New England Journal of Medicine·Anthony H BarnettUNKNOWN Diabetics Exposed to Telmisartan and Enalapril Study Group
Jul 29, 2005·The New England Journal of Medicine·Peter K LindenauerEvan M Benjamin
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Dec 8, 2006·Seminars in Dialysis·Andrew R Haas, Paul E Marik

❮ Previous
Next ❯

Citations

Aug 7, 2012·Current Hypertension Reports·Susan F Lien, John D Bisognano
Sep 23, 2014·Revista española de anestesiología y reanimación·A Zuleta-AlarcónS Bergese
Apr 16, 2011·Journal of Cardiothoracic and Vascular Anesthesia·Solomon Aronson, Joseph Varon
Sep 16, 2014·Frontiers in Pharmacology·Lakshmi N KurnutalaSergio D Bergese
Sep 25, 2014·Annual Review of Pharmacology and Toxicology·R D FeldmanS W Tobe
Apr 6, 2019·Journal of Hypertension·Maria KoutsakiAthanasios J Manolis
Aug 24, 2011·Journal of Biomolecular Screening·Lidia V Kulemina, David A Ostrov
Mar 21, 2015·Hospital Practice·Win Myint AungBarry J Materson
Nov 23, 2019·Mayo Clinic Proceedings·Dennis M BierleKaren F Mauck
Jun 18, 2021·Journal of Perioperative Practice·Anoushka M AfonsoArmin Shahrokni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.